ZA201006793B - Oral controlled release tablet with reduced burst effect - Google Patents

Oral controlled release tablet with reduced burst effect

Info

Publication number
ZA201006793B
ZA201006793B ZA2010/06793A ZA201006793A ZA201006793B ZA 201006793 B ZA201006793 B ZA 201006793B ZA 2010/06793 A ZA2010/06793 A ZA 2010/06793A ZA 201006793 A ZA201006793 A ZA 201006793A ZA 201006793 B ZA201006793 B ZA 201006793B
Authority
ZA
South Africa
Prior art keywords
controlled release
release tablet
burst effect
oral controlled
reduced burst
Prior art date
Application number
ZA2010/06793A
Other languages
English (en)
Inventor
Yashoraj Rupsingh Zala
Nitin Bhalachandra Dharmadhikari
Original Assignee
Sun Pharma Advanced Res Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Res Co Ltd filed Critical Sun Pharma Advanced Res Co Ltd
Publication of ZA201006793B publication Critical patent/ZA201006793B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
ZA2010/06793A 2008-02-15 2010-09-22 Oral controlled release tablet with reduced burst effect ZA201006793B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN339MU2008 2008-02-15
PCT/IN2009/000106 WO2009122431A2 (en) 2008-02-15 2009-02-16 Oral controlled release tablet

Publications (1)

Publication Number Publication Date
ZA201006793B true ZA201006793B (en) 2011-05-25

Family

ID=40955347

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/06793A ZA201006793B (en) 2008-02-15 2010-09-22 Oral controlled release tablet with reduced burst effect

Country Status (10)

Country Link
US (1) US20090208572A1 (cg-RX-API-DMAC7.html)
EP (1) EP2242485A4 (cg-RX-API-DMAC7.html)
JP (1) JP2011512349A (cg-RX-API-DMAC7.html)
KR (1) KR20100136967A (cg-RX-API-DMAC7.html)
CN (1) CN102026628A (cg-RX-API-DMAC7.html)
BR (1) BRPI0908114A2 (cg-RX-API-DMAC7.html)
CA (1) CA2715584A1 (cg-RX-API-DMAC7.html)
MX (1) MX2010008861A (cg-RX-API-DMAC7.html)
WO (1) WO2009122431A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201006793B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465456B2 (en) * 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
ES2526191T3 (es) * 2002-04-26 2015-01-08 Medimmune, Llc Método para producir virus influenza B infeccioso en cultivo celular
CN1757093A (zh) 2002-08-19 2006-04-05 纽约市哥伦比亚大学托管会 具有多种照射图形的单步半导体处理系统和方法
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
JP4771959B2 (ja) * 2003-12-23 2011-09-14 メディミューン，エルエルシー インフルエンザウイルス作製のための多重プラスミド系
CA2690196A1 (en) * 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide
JP2012528799A (ja) * 2009-06-02 2012-11-15 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
US20120207825A1 (en) * 2009-09-17 2012-08-16 Sunilendu Bhushan Roy Pharmaceutical compositions for reducing alcohol-induced dose dumping
US8901113B2 (en) * 2009-09-30 2014-12-02 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
EP2714015B1 (en) * 2011-06-01 2017-03-15 FMC Corporation Controlled release solid dose forms
RU2018141241A (ru) 2012-11-30 2019-01-24 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
EA030138B1 (ru) * 2016-06-15 2018-06-29 Общество С Ограниченной Ответственностью "Фармадиол" Фармацевтические композиции, включающие антикоагулянт n-(5-хлорпиридин-2-ил)-2-({4-[этанимидоил(метил)амино]бензоил}амино)-5-метилбензамид
IT201800011125A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide comprendenti matrici monolitiche complesse per la somministrazione cronotropica di medicamenti nel tratto gastroenterico
US20230226080A1 (en) * 2020-05-08 2023-07-20 Janssen Pharmaceutica Nv Treatments of prostate cancer with combinations of abiraterone acetate and niraparib
WO2025137498A1 (en) * 2023-12-20 2025-06-26 Areteia Therapeutics, Inc. Matrix tablets of dexpramipexole and methods of manufacturing and use thereof
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
EP0664118B1 (en) * 1991-10-04 1999-08-25 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release tablet
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
SK281193B6 (sk) * 1993-05-15 2001-01-18 Roche Diagnostics Gmbh Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
EP0951279A1 (en) * 1997-01-10 1999-10-27 Abbott Laboratories Tablet for the controlled release of active agents
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
YU35302A (sh) * 1999-12-23 2005-03-15 Pfizer Products Inc. Dozirani oblik leka sa inicijalnim hidrogelom
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
IL159715A0 (en) * 2001-07-10 2004-06-20 Teva Pharma Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
CN1856299B (zh) * 2003-09-19 2013-09-04 太阳医药工业有限公司 口服药物释出系统
US20060193912A1 (en) * 2005-02-28 2006-08-31 Penwest Pharmaceuticals Co. Controlled release O-desmethylvenlafaxine formulations
US20080213381A1 (en) * 2005-03-14 2008-09-04 Pharmaceutical Industries Limited Oral Drug Delivery System
JP5161075B2 (ja) * 2005-06-03 2013-03-13 エガレット エイ／エス 分散媒体の第１フラクションとマトリックスの第２フラクションを有し、第２フラクションが胃腸の液体に少なくとも部分的に最初に曝される固形の医薬組成物
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
WO2007057762A2 (en) * 2005-11-16 2007-05-24 Pfizer Limited Osmotic bi-layer tablet
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration

Also Published As

Publication number Publication date
CN102026628A (zh) 2011-04-20
US20090208572A1 (en) 2009-08-20
EP2242485A4 (en) 2013-05-08
WO2009122431A3 (en) 2010-01-07
WO2009122431A2 (en) 2009-10-08
CA2715584A1 (en) 2009-10-08
KR20100136967A (ko) 2010-12-29
MX2010008861A (es) 2011-02-22
BRPI0908114A2 (pt) 2015-10-06
JP2011512349A (ja) 2011-04-21
EP2242485A2 (en) 2010-10-27

Similar Documents

Publication Publication Date Title
ZA201006793B (en) Oral controlled release tablet with reduced burst effect
IL213247A0 (en) Ulipristal acetate tablets
PT2345410T (pt) Composição farmacêutica para libertação modificada
LT2498759T (lt) Greito atpalaidavimo tabletės kompozicijos
IL237392B (en) Pharmaceutical combination
EP2345399A4 (en) TABLE FEEDING SYSTEM
EP2379059A4 (en) COMPOSITION WITH CONTROLLED RELEASE
ZA201109445B (en) Hot-melt extruded controlled release dosage form
PL2481796T3 (pl) Odmiany glukoamylazy
IL207378A0 (en) Pharmaceutical solid state forms
IL208486A0 (en) Solid pharmaceutical formulation with delayed release
EP2263661A4 (en) ORAL PREPARATION
IL208953A0 (en) Pharmaceutical combination
GB0803054D0 (en) Medicament
EP2343059A4 (en) ORAL PREPARATION
ZA201104564B (en) Low dosage controlled release tablet
ZA201109084B (en) Burst drug release compositions
HU0800414D0 (en) Pharmaceutical combination
GB0803395D0 (en) Medicament
AU323664S (en) Pacifier